Serum - Protection from birth onwards
Flat urothelial cell carcinoma in situ (CIS) of the bladder
As adjunct therapy post TUR of primary or recurrent superficial papillary urothelial cell carcinoma (stage Ta, T1)
80 - 120 mg per instillation
Therapy should start atleast two to three weeks after Transurethral Resection of Bladder Tumour (TURBT)
One instillation per week for 6 weeks.